Standout Papers

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor 2020 2026 2022 202412.8k
  1. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor (2020)
    Markus Hoffmann, Hannah Kleine‐Weber et al. Cell
  2. A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells (2020)
    Markus Hoffmann, Hannah Kleine‐Weber et al. Molecular Cell

Immediate Impact

6 by Nobel laureates 24 from Science/Nature 55 standout
Sub-graph 1 of 22

Citing Papers

SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency
2024 Standout
Angiotensin-converting enzyme 2—at the heart of the COVID-19 pandemic
2023 Standout

Works of Hannah Kleine‐Weber being referenced

SARS-CoV-2 mutations acquired in mink reduce antibody-mediated neutralization
2021
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
2020 Standout
and 1 more

Author Peers

Author Last Decade Papers Cites
Hannah Kleine‐Weber 11159 820 558 3306 2689 11 14.7k
Simon Schroeder 9701 581 455 3092 2311 8 13.0k
Nadine Krüger 11353 767 521 3252 2712 40 14.9k
Tanja Herrler 9577 553 566 3206 3407 40 15.7k
Tobias S. Schiergens 9608 563 510 3085 2481 79 14.0k
Yushun Wan 6691 754 286 1362 2179 28 8.9k
Markus Hoffmann 13793 1180 740 3530 3580 113 18.2k
Jian Shang 7260 1026 403 1405 2032 56 9.3k
Yi Hu 6486 543 248 1802 1758 43 9.5k
Alexandra C. Walls 9238 1554 618 991 3678 32 11.5k
M. Alejandra Tortorici 9182 1784 697 962 3074 40 11.3k

All Works

Loading papers...

Rankless by CCL
2026